Infections are rising across Canada as the country deals with the so-called triple threat of respiratory illnesses, with one pediatric specialist warning amid a moderately severe influenza season that it s important to protect vulnerable populations especially young children, who are at higher risk of developing complications.
Health Canada has approved a new Respiratory Syncytial Virus (RSV) vaccine geared toward protecting two of the groups most severely affected by the virus: newborns, who would receive antibodies through maternal immunization, and Canadians over 60.